Global Nucleic Acid Drugs Competitive Landscape Professional Research Report 2024

Research Summary

Nucleic acid drugs are a class of therapeutic agents that utilize nucleic acids, such as DNA or RNA, to treat diseases by targeting specific genetic sequences or processes within cells. These drugs can modulate gene expression, inhibit the production of disease-causing proteins, or correct genetic mutations responsible for various disorders. There are several types of nucleic acid drugs, including antisense oligonucleotides, small interfering RNA (siRNA), messenger RNA (mRNA), and gene editing tools like CRISPR-Cas9. Antisense oligonucleotides bind to target RNA molecules, preventing their translation into proteins or promoting their degradation. siRNA molecules silence specific genes by triggering RNA interference pathways, while mRNA therapies deliver exogenous mRNA to produce therapeutic proteins within cells. Gene editing tools like CRISPR-Cas9 enable precise modification of DNA sequences to correct genetic mutations or engineer desired changes in the genome. Nucleic acid drugs hold promise for treating a wide range of diseases, including genetic disorders, cancer, viral infections, and inflammatory conditions, offering potential advantages such as specificity, potency, and the ability to target previously ? 1/4 ?undruggable? 1/4 ? targets. However, challenges remain in optimizing delivery methods, ensuring safety, and overcoming off-target effects to fully realize their therapeutic potential.

According to DIResearch's in-depth investigation and research, the global Nucleic Acid Drugs market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Nucleic Acid Drugs include Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, Sobi, Novartis, BioNTech, Pfizer, Moderna Therapeutics, Jazz Pharmaceuticals, CureVac, Regulus Therapeutics, ProQR, Secarna, MiNA Therapeutics, Sylentis, Arrowhead, Silence Therapeutics, Dicerna etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Nucleic Acid Drugs. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Nucleic Acid Drugs market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Nucleic Acid Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Nucleic Acid Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Nucleic Acid Drugs Include:

Sarepta Therapeutics

Ionis Pharmaceuticals

Alnylam

Biogen

Nippon Shinyaku

Sobi

Novartis

BioNTech

Pfizer

Moderna Therapeutics

Jazz Pharmaceuticals

CureVac

Regulus Therapeutics

ProQR

Secarna

MiNA Therapeutics

Sylentis

Arrowhead

Silence Therapeutics

Dicerna

Nucleic Acid Drugs Product Segment Include:

Antisense Oligonucleotides (ASO)

siRNA

mRNA

Nucleic Acid Drugs Product Application Include:

Neuromuscular Diseases

hATTR

COVID-19

Other

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Nucleic Acid Drugs Industry PESTEL Analysis

Chapter 3: Global Nucleic Acid Drugs Industry Porter's Five Forces Analysis

Chapter 4: Global Nucleic Acid Drugs Major Regional Market Size and Forecast Analysis

Chapter 5: Global Nucleic Acid Drugs Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Nucleic Acid Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Nucleic Acid Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Nucleic Acid Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Nucleic Acid Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Nucleic Acid Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Nucleic Acid Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Nucleic Acid Drugs Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Nucleic Acid Drugs Market Overview

1.1 Product Definition and Statistical Scope

1.2 Nucleic Acid Drugs Product by Type

1.2.1 Global Nucleic Acid Drugs Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Antisense Oligonucleotides (ASO)

1.2.3 siRNA

1.2.4 mRNA

1.3 Nucleic Acid Drugs Product by Application

1.3.1 Global Nucleic Acid Drugs Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Neuromuscular Diseases

1.3.3 hATTR

1.3.4 COVID-19

1.3.5 Other

1.4 Global Nucleic Acid Drugs Market Revenue Analysis (2019-2030)

1.5 Nucleic Acid Drugs Market Development Status and Trends

1.5.1 Nucleic Acid Drugs Industry Development Status Analysis

1.5.2 Nucleic Acid Drugs Industry Development Trends Analysis

2 Nucleic Acid Drugs Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Nucleic Acid Drugs Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Nucleic Acid Drugs Market Analysis by Regions

4.1 Nucleic Acid Drugs Overall Market: 2023 VS 2024 VS 2030

4.2 Global Nucleic Acid Drugs Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Nucleic Acid Drugs Revenue and Market Share by Region (2019-2024)

4.2.2 Global Nucleic Acid Drugs Revenue Forecast by Region (2025-2030)

5 Global Nucleic Acid Drugs Market Size by Type and Application

5.1 Global Nucleic Acid Drugs Market Size by Type

5.2 Global Nucleic Acid Drugs Market Size by Application

6 North America

6.1 North America Nucleic Acid Drugs Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Nucleic Acid Drugs Market Size by Type

6.4 North America Nucleic Acid Drugs Market Size by Application

6.5 North America Nucleic Acid Drugs Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Nucleic Acid Drugs Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Nucleic Acid Drugs Market Size by Type

7.4 Europe Nucleic Acid Drugs Market Size by Application

7.5 Europe Nucleic Acid Drugs Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Nucleic Acid Drugs Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Nucleic Acid Drugs Market Size by Type

8.4 China Nucleic Acid Drugs Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Nucleic Acid Drugs Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Nucleic Acid Drugs Market Size by Type

9.4 APAC (excl. China) Nucleic Acid Drugs Market Size by Application

9.5 APAC (excl. China) Nucleic Acid Drugs Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Nucleic Acid Drugs Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Nucleic Acid Drugs Market Size by Type

10.4 Latin America Nucleic Acid Drugs Market Size by Application

10.5 Latin America Nucleic Acid Drugs Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Nucleic Acid Drugs Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Nucleic Acid Drugs Market Size by Type

11.4 Middle East & Africa Nucleic Acid Drugs Market Size by Application

11.5 Middle East & Africa Nucleic Acid Drugs Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Nucleic Acid Drugs Market Revenue by Key Manufacturers (2020-2024)

12.2 Nucleic Acid Drugs Competitive Landscape Analysis and Market Dynamic

12.2.1 Nucleic Acid Drugs Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Sarepta Therapeutics

13.1.1 Sarepta Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Sarepta Therapeutics Nucleic Acid Drugs Product Portfolio

13.1.3 Sarepta Therapeutics Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Ionis Pharmaceuticals

13.2.1 Ionis Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Ionis Pharmaceuticals Nucleic Acid Drugs Product Portfolio

13.2.3 Ionis Pharmaceuticals Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Alnylam

13.3.1 Alnylam Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Alnylam Nucleic Acid Drugs Product Portfolio

13.3.3 Alnylam Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Biogen

13.4.1 Biogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Biogen Nucleic Acid Drugs Product Portfolio

13.4.3 Biogen Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Nippon Shinyaku

13.5.1 Nippon Shinyaku Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Nippon Shinyaku Nucleic Acid Drugs Product Portfolio

13.5.3 Nippon Shinyaku Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Sobi

13.6.1 Sobi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Sobi Nucleic Acid Drugs Product Portfolio

13.6.3 Sobi Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Novartis

13.7.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Novartis Nucleic Acid Drugs Product Portfolio

13.7.3 Novartis Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 BioNTech

13.8.1 BioNTech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 BioNTech Nucleic Acid Drugs Product Portfolio

13.8.3 BioNTech Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Pfizer

13.9.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Pfizer Nucleic Acid Drugs Product Portfolio

13.9.3 Pfizer Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Moderna Therapeutics

13.10.1 Moderna Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Moderna Therapeutics Nucleic Acid Drugs Product Portfolio

13.10.3 Moderna Therapeutics Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Jazz Pharmaceuticals

13.11.1 Jazz Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Jazz Pharmaceuticals Nucleic Acid Drugs Product Portfolio

13.11.3 Jazz Pharmaceuticals Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 CureVac

13.12.1 CureVac Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 CureVac Nucleic Acid Drugs Product Portfolio

13.12.3 CureVac Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Regulus Therapeutics

13.13.1 Regulus Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Regulus Therapeutics Nucleic Acid Drugs Product Portfolio

13.13.3 Regulus Therapeutics Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 ProQR

13.14.1 ProQR Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 ProQR Nucleic Acid Drugs Product Portfolio

13.14.3 ProQR Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.15 Secarna

13.15.1 Secarna Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 Secarna Nucleic Acid Drugs Product Portfolio

13.15.3 Secarna Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.16 MiNA Therapeutics

13.16.1 MiNA Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.16.2 MiNA Therapeutics Nucleic Acid Drugs Product Portfolio

13.16.3 MiNA Therapeutics Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.17 Sylentis

13.17.1 Sylentis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.17.2 Sylentis Nucleic Acid Drugs Product Portfolio

13.17.3 Sylentis Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.18 Arrowhead

13.18.1 Arrowhead Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.18.2 Arrowhead Nucleic Acid Drugs Product Portfolio

13.18.3 Arrowhead Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.19 Silence Therapeutics

13.19.1 Silence Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.19.2 Silence Therapeutics Nucleic Acid Drugs Product Portfolio

13.19.3 Silence Therapeutics Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.20 Dicerna

13.20.1 Dicerna Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.20.2 Dicerna Nucleic Acid Drugs Product Portfolio

13.20.3 Dicerna Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Nucleic Acid Drugs Industry Chain Analysis

14.2 Nucleic Acid Drugs Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Nucleic Acid Drugs Typical Downstream Customers

14.4 Nucleic Acid Drugs Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support